Clough Capital Partners’s Abbott ABT Stock Holding History

Clough Capital Partners’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-46,000	Closed	-$5.45M	–	80
2022 Q1	$5.45M	Buy	+46,000	New	+$5.7M	0.41%	62

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clough Capital Partners's ABT Position: Q2 2022 in Review

Clough Capital Partners sold out of Abbott (ABT) in Q2 2022, closing a stake of 46,000 shares — an estimated $5.45M sold.

Clough Capital Partners first reported a position in ABT in Q1 2022 and held it in 1 quarter. The position peaked at $5.45M in Q1 2022. 2,697 funds tracked by Wall St. Rank hold ABT as of Q2 2022.

Clough Capital Partners reported no remaining Abbott position as of Q2 2022 after selling out during the quarter.
Clough Capital Partners sold 46,000 Abbott shares in Q2 2022, an estimated $5.45M.
Clough Capital Partners first reported a position in Abbott in Q1 2022 and held it in 1 quarter.
Clough Capital Partners's Abbott position peaked at $5.45M in Q1 2022.
2,697 funds tracked by Wall St. Rank held Abbott as of Q2 2022.

Based on Clough Capital Partners's 13F filing for Q2 2022, filed 16 Aug 2022.